These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9131249)

  • 21. [Transgenic rats as a model for investigation of the pathogenesis of hypertension].
    Paul M
    Z Kardiol; 1995; 84 Suppl 4():55-60. PubMed ID: 8585274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of Cre recombinase-expressing transgenic mice using bacterial artificial chromosomes.
    Parkitna JR; Engblom D; Schütz G
    Methods Mol Biol; 2009; 530():325-42. PubMed ID: 19266340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic and gene disruption techniques in the study of neurocarcinogenesis.
    Aguzzi A; Brandner S; Isenmann S; Steinbach JP; Sure U
    Glia; 1995 Nov; 15(3):348-64. PubMed ID: 8586469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristic of segments of transgenic animal genomes, adjacent to integrated sequences of foreign DNA].
    Tarantul VZ; Kuznetsova ED; Gazarian KG
    Mol Biol (Mosk); 1989; 23(4):1036-40. PubMed ID: 2586499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifelong genetic minipumps.
    Caron KM; James LR; Lee G; Kim HS; Smithies O
    Physiol Genomics; 2005 Jan; 20(2):203-9. PubMed ID: 15585607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs.
    Ramsoondar J; Vaught T; Ball S; Mendicino M; Monahan J; Jobst P; Vance A; Duncan J; Wells K; Ayares D
    Xenotransplantation; 2009; 16(3):164-80. PubMed ID: 19566656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring type I angiotensin (AT1) receptor functions through gene targeting.
    Crowley SD; Tharaux PL; Audoly LP; Coffman TM
    Acta Physiol Scand; 2004 Aug; 181(4):561-70. PubMed ID: 15283771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application and recent advances of laboratory mouse in human cancer research].
    Liu EQ; Kitajima S; Morimoto M
    Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic rats: tools to study the function of the renin-angiotensin system.
    Bader M; Ganten D
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S81-7. PubMed ID: 21143278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic dissection of the renin-angiotensin system].
    Fukamizu A
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():42-8. PubMed ID: 15813042
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic engineering of neural function in transgenic rodents: towards a comprehensive strategy?
    Wells T; Carter DA
    J Neurosci Methods; 2001 Jul; 108(2):111-30. PubMed ID: 11478971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic targeting of cerebellar Purkinje cells: history, current status and novel strategies.
    Barski JJ; Lauth M; Meyer M
    Cerebellum; 2002 Apr; 1(2):111-8. PubMed ID: 12882360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced transgenic and gene-targeting approaches.
    Gao X; Kemper A; Popko B
    Neurochem Res; 1999 Sep; 24(9):1181-8. PubMed ID: 10485590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic animals as models for human disease.
    Wagner J; Thiele F; Ganten D
    Clin Exp Hypertens; 1995 May; 17(4):593-605. PubMed ID: 7795575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically manipulated animals and their use in experimental research.
    Ge R
    Ann Acad Med Singap; 1999 Jul; 28(4):560-4. PubMed ID: 10561771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic animal models for neuropharmacology.
    Bader M
    Rev Neurosci; 2000; 11(1):27-36. PubMed ID: 10716652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concepts, potentials and methods for constructing transgenic cells and animals.
    Buerki K
    Arch Toxicol Suppl; 1995; 17():3-7. PubMed ID: 7786166
    [No Abstract]   [Full Text] [Related]  

  • 39. Transgenic animals as bioreactors for pharmacological products.
    Costa P; Sassano M; Righi M; Ricciardi-Castagnoli P
    Pharmacol Res; 1990; 22(2):75-8. PubMed ID: 2184424
    [No Abstract]   [Full Text] [Related]  

  • 40. A Study on Merits and Demerits of Two Main Gene Silencing Techniques in Mice.
    Khezri J; Heidari F; Shamsara M
    Iran J Biotechnol; 2018 Aug; 16(3):e1632. PubMed ID: 31457022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.